## SE: Sea Limited - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.42 indicates fundamental undervaluation. Quality metrics strong (ROE 16%). Caution: momentum weakening (-2.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($115.18)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Barclays | $226 | $214 | +6% |
| 2025-11-12 | Deutsche Bank | $170 | $165 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Barclays | main | Overweight |
| 2025-11-12 | Deutsche Bank | up | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 9.1% (+163.7%)
- BAILLIE GIFFORD & CO: 7.4% (-3.7%)
- WCM Investment Manag: 4.8% (+0.9%)
- Blackrock Inc.: 3.8% (+2.1%)
- Price (T.Rowe) Assoc: 3.1% (+8.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.4% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 17.8% below SMA200.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.42 indicates undervaluation relative to growth. Forward P/E 24.9x attractive for 45% earnings growth. Revenue growth strong at 24% YoY. Institutional flow bullish (6 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $74.9B |
| Beta | 1.58 |
| 52W Range | $99.50 - $199.30 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.42 |
| Forward P/E | 24.9 |
| Current P/E | 36.1 |
| YoY Growth | 45.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -6.3% to -8.7% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 12.7pp (needs >4.0% for momentum thesis). AM_20 at -6.6% indicates price below own 20MA trend. Underperforming sector by 9.6pp, stock-specific weakness. Below SMA200 (0.82x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -8.66% (CS: 2) | Weak |
| RSI_14 | 33.6 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 0.934x | Below |
| vs SMA50 | 0.825x | Below |
| vs SMA200 | 0.822x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $126.60
- **Stop Loss:** $115.18 (9.0% risk)
- **Target:** $149.44 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 120
- **Position Value:** $15,192.00
- **Portfolio %:** 15.19%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-03-03 (Est: $0.87)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.95 | $0.76 | -19.8% |
| 2025Q2 | $0.88 | $0.84 | -4.2% |
| 2025Q1 | $0.91 | $0.83 | -8.7% |
| 2024Q4 | $0.69 | $0.60 | -13.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*